IP Library Granted Patent US 10,987,468
Granted Patent B2
US 10,987,468 · App. 15/384,493 · Granted Apr 27, 2021

Operating multi-modal medicine delivery systems

Inventors: Bryan Mazlish (Palo Alto, CA); Lane Desborough (Thousand Oaks, CA)
Assignee: Bigfoot Biomedical, Inc.
A61M5/1723A61M5/1407A61M5/1452A61M5/14244G16H20/17A61M5/14276A61M2205/3306A61M2205/3553A61M2205/3561A61M2205/3584A61M2205/502A61M2205/52A61M2205/6009A61M2205/702A61M2230/005A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,987,468
App. No.
15/384,493
Granted
Apr 27, 2021
Kind
B2
Abstract

A multi-modal medicine delivery system in which some embodiments can be configured to control dispensation of medicine according to any of a plurality of delivery modes, such as by closed-loop delivery modes and open-loop delivery modes, and according to a secondary feedback loop to determine user-specific settings related to dosage delivery.

Claims (26)

1. A method for delivering one or more medications from a multi-modal medicine delivery system, comprising:

selecting a first delivery mode from among a plurality of delivery modes to use for operating a multi-modal medicine delivery system to dispense one or more medications adapted to alter a blood analyte level;

delivering the one or more medications to a user according to the first delivery mode, the first delivery mode delivering amounts of the one or more medications according to a primary feedback loop that uses analyte sensor data and user-specific dosage parameters to determine at least some of the amounts of the one or more medications to deliver over time without user interaction;

obtaining, while the multi-modal medicine delivery system is operating according to and without exiting the first delivery mode, (i) the analyte sensor data and (ii) one or both of medicine delivery data and food intake data, the analyte sensor data being generated by an analyte sensor and indicating the blood analyte level for the user at one or more specific times, the medicine delivery data identifying amounts and times at which the one or more medications were delivered to the user, the food intake data identifying amounts and times at which one or more foods were consumed by the user;

determining, using a secondary feedback loop, one or more updates to the user-specific dosage parameters based on the analyte sensor data and (ii) the one or both of the medicine delivery data and the food intake data;

delivering the one or more medications to the user according to the first delivery mode using the analyte sensor data and the updated user-specific dosage parameters to determine at least some of the amounts of the one or more medications to deliver over time without user interaction; and

switching to a second delivery mode delivering the one or more medications to the user according to the second delivery mode using the updated user-specific dosage parameters to determine a schedule of basal dosages of the one or more medications, and

while the multi-modal medicine delivery system is operating according to and without exiting the second delivery mode, performing the following:

obtaining additional analyte sensor data and additional medicine delivery data from operation of the multi-modal medicine delivery system according to the second delivery mode and the updated user-specific dosage parameters;

determining, using the secondary feedback loop, one or more additional updates to the user-specific dosage parameters based on (i) the additional analyte sensor data and (ii) the additional medicine delivery data; and

delivering the one or more medications to the user according to the second delivery mode based upon the additional updates to the user-specific dosage parameters.

2. The method of claim 1 , wherein the multi-modal medicine delivery system comprises a portable insulin infusion pump system, the analyte sensor data comprises data describing blood glucose readings, and the medicine delivery data identifies insulin dosages delivered to the user from the portable insulin infusion pump system.

3. The method of claim 2 , wherein switching to the second delivery mode comprises:

determining whether to transition out of operating the multi-modal medicine delivery system according to the first delivery mode;

selecting, in response to a determination to transition out of operating according to the first delivery mode, the second delivery mode to use for operating the multi-modal medicine delivery system from among the plurality of delivery modes; and

operating the multi-modal medicine delivery system to dispense the one or more medications according to the second delivery mode and the updated user-specific dosage parameters.

4. The method of claim 1 , wherein the secondary feedback loop determines the additional updates to the user-specific dosage parameters based on both (i) the analyte sensor data and the medicine delivery data generated during the first delivery mode, and (ii) the additional analyte sensor data and the additional medicine delivery data generated during the second delivery mode.

5. The method of claim 1 , wherein detecting a transition trigger event comprises detecting the transition trigger event automatically without user input.

6. The method of claim 1 , wherein detecting a transition trigger event comprises detecting a signal to the analyte sensor being lost or acquired.

7. The method of claim 1 , wherein detecting a transition trigger event comprises detecting an expiration of a period of time for operating the multi-modal medicine delivery system according to the first delivery mode.

8. The method of claim 1 , wherein a transition trigger event comprises detecting that one or more calibrations for one or more components of the multi-modal medicine delivery system has failed to be completed after a period of time.

9. The method of claim 1 , wherein detecting a transition trigger event comprises detecting a scheduled transition in a time-based schedule for a patient using the multi-modal medicine delivery system.

10. The method of claim 1 , wherein detecting a transition trigger event comprises detecting one or more components of the multi-modal medicine delivery system failing one or more safety checks.

11. The method of claim 1 , wherein detecting a transition trigger event comprises detecting a user input to the multi-modal medicine delivery system.

12. The method of claim 1 , wherein selecting the first delivery mode from among the plurality of delivery modes comprises:

selecting the first delivery mode from a group comprising: a closed-loop delivery mode and an open-loop delivery mode, wherein the first delivery mode is a closed-loop delivery mode and the second delivery mode is an open-loop delivery mode.

Assignments (16)
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY AGREEMENT SUPPLEMENT Recorded Sep 7, 2023
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 064840/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2023
From: BIGFOOT BIOMEDICAL, INC.
To: INSULET CORPORATION
Reel/Frame 062900/0001 →
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 062793/0316 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2017
From: MAZLISH, BRYAN; DESBOROUGH, LANE
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 041015/0820 →
Continuity (2)
Provisional Application 62275213 · Jan 5, 2016
Related Publication 20170189614A1 · Jul 6, 2017
Cited By (38)
US 12,226,612 US 12,296,139 US 12,303,667 US 12,303,668 US 12,318,577 US 12,343,502 US 12,370,307 US 12,370,309 US 12,383,166 US 12,406,760 US 12,409,270 US 12,427,251 US 12,431,229 US 12,431,230 US 12,485,223 US 12,495,994 US 12,496,398 US 12,514,979 US 12,514,980 US 12,521,486 US 12,551,619 US 12,551,621 US 12,558,026 US 12,562,251 US 12,564,679 US 12,569,619 US 12,592,306 US 12,636,435 US 12,646,601 US 12,651,659 US 12,653,949 US 12,667,665 US 12,678,556 US 12,691,221 US 12,691,222 US 12,708,709 US 12,714,785 US 12,718,918